Development and in-vitro evaluation of Furosemide Solid Dispersion using different Water Soluble Carriers
Journal Title: International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL) - Year 2017, Vol 6, Issue 2
Abstract
Objective: The objective of the present investigation was to improve solubility and dissolution characteristics of Furosemide, which might offer improved bioavailability. The bioavailability of the drug when taken orally is limited by the relatively low solubility. Furosemide is a loop diuretic (a ‘water pill’) used to treat congestive heart failure, oedema and sometimes hypertension. Method: The solid dispersion of Furosemide was prepared by Solvent evaporation method by using 1:1, 1:2 and 1:3 ratios of drug and polymers (PVP K-30, PEG6000). The solid dispersion was prepared by solvent evaporation method. The prepared solid dispersion was evaluated for various parameters like uniformity of drug content, in-vitro drug release and short term stability studies. Results: The prepared dispersion showed marked increase in the dissolution rate of Furosemide than that of pure drug and the in vitro release studies revealed that there was an improvement in the dissolution characteristics of drug when prepared as solid dispersions. Solid dispersion with PEG 6000 and PVPK30 gave better rate and extent of dissolution. Conclusion: It can be concluded that the solid dispersions prepared with PEG6000 and PVP K30 and among all the formulations, F6 has highest solubility and in vitro dissolution rate.
Authors and Affiliations
Lokesh Soni| NRI Institute of Pharmaceutical Sciences, Bhopal, India, Mojammil Ansari| NRI Institute of Pharmaceutical Sciences, Bhopal, India, Nisha Thakre| NRI Institute of Pharmaceutical Sciences, Bhopal, India, Anjita Singh| NRI Institute of Pharmaceutical Sciences, Bhopal, India, Mithun Bhowmick| NRI Institute of Pharmaceutical Sciences, Bhopal, India, Jagdish Rathi| NRI Institute of Pharmaceutical Sciences, Bhopal, India
Keywords
Related Articles
- EP ID EP16009
- DOI -
- Views 364
- Downloads 15
Design and evaluation of a Sustained Release Gastroretentive Dosage form of Captopril
Sustained drug delivery means not only prolonged duration of drug delivery but also implies predictability and reproducibility of drug release kinetics. In the present study gastroretentive dosage form (tablet) was sel...
Formulation and characterization of mouth dissolving mucoadhesive buccal film of Zolmitriptan
Fast dissolving buccal film drug delivery system is an alternative to tablets, capsules, and syrups for pediatric and geriatric patients who experience in difficulties of swallowing traditional oral solid dosage forms....
Formulation development and evaluation of Telmisartan Nanoemulsion
The aim of the present study was to development of oral nanoemulsion formulation of telmisartan belong to BCS class 2nd, It have low solubility and low permeability. Therefore, oral nanoemulsion containing Telmisartan...
Synthesis and biological activity of some novel Combretastatin analogues and related compounds
CA-4 is a biologically very active compound by binding to the colchicine binding site which lead to the inhibition of microtubule polymerization as well as showing antiagiogenic and anticancer effects by selectively sh...
A validated analytical method for the estimation of Oxetacaine from its pharmaceutical formulation by RP-HPLC
OBJECTIVE: The aim of the current study was to develop an analytical procedure for the determination and quantification of Oxetacaine, from its marketed formulation which is simple, precise, accurate and a validated, r...